Core Scientific, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $65.1M | $49.0M | $16.2M | $58.9M |
| FY2024 | $42.9M | $-52.1M | $95.0M | $51.9M |
| FY2025 | $278.3M | $-450.8M | $729.0M | $98.2M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $65.1M | $49.0M | $16.2M | $58.9M |
| FY2024 | $42.9M | $-52.1M | $95.0M | $51.9M |
| FY2025 | $278.3M | $-450.8M | $729.0M | $98.2M |